Vagal Blocking for Obesity Control
|ClinicalTrials.gov Identifier: NCT00555958|
Recruitment Status : Unknown
Verified February 2012 by EnteroMedics.
Recruitment status was: Active, not recruiting
First Posted : November 9, 2007
Last Update Posted : February 2, 2012
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Actual Primary Completion Date :||September 2011|
|Estimated Study Completion Date :||September 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Shikora S, Toouli J, Herrera MF, Kulseng B, Zulewski H, Brancatisano R, Kow L, Pantoja JP, Johnsen G, Brancatisano A, Tweden KS, Knudson MB, Billington CJ. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus. J Obes. 2013;2013:245683. doi: 10.1155/2013/245683. Epub 2013 Jul 30.